Investing

MindMed : MNMD

MNMD

Stock Data

$0.69

$0.02 (3.40%)

Asset Type

N/A

Exchange

N/A

Currency

N/A

Country

N/A

Sector

N/A

Industry

N/A

Mind Medicine (MindMed) Inc. is a pioneering biopharmaceutical company focused on developing innovative treatments for brain health disorders. With a robust pipeline, its leading products include MM-120, aimed at addressing generalized anxiety disorder and attention deficit hyperactivity disorder, and MM-402, targeting autism spectrum disorder symptoms. Additionally, MindMed is exploring MM-110 for opioid withdrawal relief. Based in New York, New York, the company is at the forefront of addressing complex mental health challenges.

All MindMed Articles

2 Articles

Paul Ausick | Mar 24, 2022 at 11:16 AM EDT

Earnings Previews: Bitfarms, Mind Medicine, SAIC, Xpeng

Here are previews of four interesting companies set to report quarterly results before markets open on Monday.

Paul Ausick | Sep 8, 2021 at 12:39 PM EDT

Time to Buy the Magic Stocks? Magic Mushrooms, That Is.

Here's a quick look at six publicly traded companies developing ways to use psychedelics to treat mental health issues.